Singapore: AstraZeneca is looking to move its research and global headquarters to Cambridge, UK, and has zeroed in on a site located at the south of the city. The firm's new headquarters is expected to be worth $500 million and will also... Read more
Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in... Read more
Singapore: Malaysia-based Pharmaniaga has entered into a collaboration with Saudi Arabia-based Modern Healthcare Solutions... Read more
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the... Read more
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption,... Read more
India's growing ability to innovate and provide efficient and cost-effective solutions to various bioscience problems plaguing the nation... Read more
The Central Drugs Standard Control Organization and Department of Biotechnology mutually formed and implemented the national regulatory... Read more
Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209 abstracts from... Read more
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds... Read more
Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange... Read more
New Delhi: It seems like the troubles for India's Union Cabinet Minister for Railways, Mr Pawan Kumar Bansal, may not have subsided yet.... Read more
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatment of genotype (GT1)... Read more
Survey Box